Park National Corp Astrazeneca PLC Transaction History

Park National Corp

$2.82 Billion
Q3 2024

A detailed history of Park National Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Park National Corp holds 153,221 shares of AZN stock, worth $10.2 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

153,221

Previous 161,382 5.06%

Holding current value

$10.2 Million

Previous $12.6 Million 5.15%

% of portfolio

0.42%

Previous 0.47%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$76.67 - $87.62 $625,703 - $715,066	-8,161 Reduced 5.06%	153,221 $11.9 Million
Q2 2024 Jul 15, 2024	BUY	$66.81 - $80.83 $1.3 Million - $1.58 Million	19,499 Added 13.74%	161,382 $12.6 Million
Q1 2024 Apr 01, 2024	SELL	$61.03 - $69.57 $260,170 - $296,576	-4,263 Reduced 2.92%	141,883 $9.61 Million
Q4 2023 Jan 02, 2024	BUY	$61.89 - $69.28 $445,360 - $498,538	7,196 Added 5.18%	146,146 $9.84 Million
Q3 2023 Oct 02, 2023	SELL	$64.85 - $71.7 $116,794 - $129,131	-1,801 Reduced 1.28%	138,950 $9.41 Million
Q2 2023 Jul 03, 2023	SELL	$69.91 - $75.81 $571,024 - $619,216	-8,168 Reduced 5.48%	140,751 $10.1 Million
Q1 2023 Apr 03, 2023	SELL	$63.15 - $71.6 $119,100 - $135,037	-1,886 Reduced 1.25%	148,919 $10.3 Million
Q4 2022 Feb 06, 2023	BUY	$54.21 - $70.44 $3.8 Million - $4.93 Million	70,057 Added 86.76%	150,805 $10.2 Million
Q3 2022 Oct 03, 2022	SELL	$53.02 - $135.75 $56,625 - $144,981	-1,068 Reduced 1.31%	80,748 $4.43 Million
Q2 2022 Jul 01, 2022	SELL	$59.26 - $71.14 $838,766 - $1.01 Million	-14,154 Reduced 14.75%	81,816 $5.41 Million
Q1 2022 Apr 01, 2022	SELL	$55.72 - $67.12 $761,915 - $917,798	-13,674 Reduced 12.47%	95,970 $6.37 Million
Q4 2021 Jan 04, 2022	SELL	$54.02 - $63.83 $1.38 Million - $1.63 Million	-25,588 Reduced 18.92%	109,644 $6.39 Million
Q3 2021 Oct 01, 2021	SELL	$55.56 - $60.79 $1.73 Million - $1.89 Million	-31,151 Reduced 18.72%	135,232 $8.12 Million
Q2 2021 Jul 01, 2021	SELL	$48.42 - $60.18 $6.95 Million - $8.64 Million	-143,512 Reduced 46.31%	166,383 $9.97 Million
Q1 2021 Apr 01, 2021	BUY	$47.16 - $54.44 $28,814 - $33,262	611 Added 0.2%	309,895 $15.4 Million
Q4 2020 Jan 04, 2021	BUY	$48.52 - $58.02 $307,859 - $368,136	6,345 Added 2.09%	309,284 $15.5 Million
Q3 2020 Oct 01, 2020	SELL	$53.07 - $61.1 $115,480 - $132,953	-2,176 Reduced 0.71%	302,939 $16.6 Million
Q2 2020 Jul 01, 2020	SELL	$43.1 - $55.31 $546,249 - $700,998	-12,674 Reduced 3.99%	305,115 $16.1 Million
Q1 2020 Apr 01, 2020	BUY	$37.79 - $51.33 $113,899 - $154,708	3,014 Added 0.96%	317,789 $14.2 Million
Q4 2019 Jan 02, 2020	BUY	$42.46 - $50.46 $427,911 - $508,535	10,078 Added 3.31%	314,775 $15.7 Million
Q3 2019 Oct 01, 2019	BUY	$40.12 - $45.47 $1.06 Million - $1.2 Million	26,426 Added 9.5%	304,697 $13.6 Million
Q2 2019 Jul 01, 2019	BUY	$37.28 - $41.68 $1.51 Million - $1.68 Million	40,391 Added 16.98%	278,271 $11.5 Million
Q1 2019 Apr 01, 2019	BUY	$35.49 - $43.02 $2.21 Million - $2.68 Million	62,399 Added 35.56%	237,880 $9.62 Million
Q4 2018 Jan 02, 2019	BUY	$36.86 - $41.49 $3.69 Million - $4.15 Million	100,111 Added 132.83%	175,481 $6.67 Million
Q3 2018 Oct 02, 2018	BUY	$34.76 - $39.72 $2.62 Million - $2.99 Million	75,370 New	75,370 $2.98 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park National Corp , based on Form 13F filings with the SEC.

News

Stay updated on Park National Corp with notifications on news.

Account

Park National Corp Astrazeneca PLC Transaction History